Daewoong Pharmaceutical Co. Ltd.

This Phase 3 trial tested whether adding a second drug (DWC202314) to an existing one (DWC202404) helps people whose high blood pressure isn't controlled by the first drug alone. 192 adults with essential hypertension took part. The study is now complete, and results will show if…

This study tested whether taking two drugs (DWC202206 and DWC202207) together is safe and effective for people with both high blood pressure and high cholesterol. 214 adults aged 19 to 80 took part. The goal was to see if the combination lowered blood pressure and LDL ("bad") cho…

This Phase 3 trial tested whether adding a third drug (DWC202314) to a two-drug combination pill works better for people with essential hypertension that isn't controlled by the two-drug pill alone. 198 participants took either the two-drug or three-drug combination once daily. T…

This study tested whether a new triple therapy containing DWP14012 is as good as the standard treatment for eradicating H. pylori, a bacteria that can cause stomach ulcers. 461 adults with confirmed H. pylori infection took part. The main goal was to see if the infection was gone…

This completed study looked at whether FEXUCLUE (fexuprazan) tablets can improve heartburn and acid reflux symptoms in people with erosive gastroesophageal reflux disease (GERD). Over 2,800 adults took the medication for 4 to 8 weeks and reported their symptom changes. The goal w…

This completed phase 1 study tested whether two experimental drugs, DWC202511 and DWC202512, change how the body processes the diabetes medicine DWP16001. Eighteen healthy adults took DWP16001 alone and then with each of the other drugs. The goal was to see if there are any drug …

This completed Phase 1 trial enrolled 70 healthy adults to compare two tablet formulations of the same drug, DWJ1445 and DWC202506. Participants received a single dose of each in random order, and researchers measured drug levels in the blood to check if the two versions are abso…